CAV1 and kidney disorder: Although based on a small group of cases for each condition, this pilot IHC analysis confirmed the reliability of focal and diffuse Cav-1 positivity (Grade II-III) to specifically detect antibody-mediated rejection injury in a wide range of kidney diseases.